These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31925635)

  • 21. Plant Soup Formulations Show Cholinesterase Inhibition Potential in the Prevention of Alzheimer's Disease.
    Gajowniczek-Ałasa D; Szwajgier D; Baranowska-Wójcik E
    Curr Alzheimer Res; 2024; 21(1):81-89. PubMed ID: 38523524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Withanolides: Biologically Active Constituents in the Treatment of Alzheimer's Disease.
    Khan SA; Khan SB; Shah Z; Asiri AM
    Med Chem; 2016; 12(3):238-56. PubMed ID: 26527154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, Characterization and Cholinesterase Inhibition Studies of New Arylidene Aminothiazolylethanone Derivatives.
    Channar PA; Shah MS; Saeed A; Khan SU; Larik FA; Shabir G; Iqbal J
    Med Chem; 2017; 13(7):648-653. PubMed ID: 28266279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment.
    Makhaeva GF; Lushchekina SV; Boltneva NP; Serebryakova OG; Rudakova EV; Ustyugov AA; Bachurin SO; Shchepochkin AV; Chupakhin ON; Charushin VN; Richardson RJ
    Bioorg Med Chem; 2017 Nov; 25(21):5981-5994. PubMed ID: 28986116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and inhibitory activities of inhibitors for the treatment of Alzheimer's disease.
    Zhou S; Huang G
    Chem Biol Drug Des; 2022 May; 99(5):727-735. PubMed ID: 34942058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholinesterases inhibition and molecular modeling studies of piperidyl-thienyl and 2-pyrazoline derivatives of chalcones.
    Shah MS; Khan SU; Ejaz SA; Afridi S; Rizvi SUF; Najam-Ul-Haq M; Iqbal J
    Biochem Biophys Res Commun; 2017 Jan; 482(4):615-624. PubMed ID: 27865835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new therapeutic target in Alzheimer's disease treatment: attention to butyrylcholinesterase.
    Greig NH; Utsuki T; Yu Q; Zhu X; Holloway HW; Perry T; Lee B; Ingram DK; Lahiri DK
    Curr Med Res Opin; 2001; 17(3):159-65. PubMed ID: 11900310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quinoxaline derivatives: novel and selective butyrylcholinesterase inhibitors.
    Zeb A; Hameed A; Khan L; Khan I; Dalvandi K; Choudhary MI; Basha FZ
    Med Chem; 2014; 10(7):724-9. PubMed ID: 24875826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-Alzheimers activity and molecular mechanism of albumin-derived peptides against AChE and BChE.
    Yu Z; Wu S; Zhao W; Ding L; Fan Y; Shiuan D; Liu J; Chen F
    Food Funct; 2018 Feb; 9(2):1173-1178. PubMed ID: 29363710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quinolizidinyl derivatives of bi- and tricyclic systems as potent inhibitors of acetyl- and butyrylcholinesterase with potential in Alzheimer's disease.
    Tasso B; Catto M; Nicolotti O; Novelli F; Tonelli M; Giangreco I; Pisani L; Sparatore A; Boido V; Carotti A; Sparatore F
    Eur J Med Chem; 2011 Jun; 46(6):2170-84. PubMed ID: 21459491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating Fmoc-amino acids as selective inhibitors of butyrylcholinesterase.
    Gonzalez J; Ramirez J; Schwans JP
    Amino Acids; 2016 Dec; 48(12):2755-2763. PubMed ID: 27522651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer's disease.
    Kumar A; Pintus F; Di Petrillo A; Medda R; Caria P; Matos MJ; Viña D; Pieroni E; Delogu F; Era B; Delogu GL; Fais A
    Sci Rep; 2018 Mar; 8(1):4424. PubMed ID: 29535344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current concepts on selected plant secondary metabolites with promising inhibitory effects against enzymes linked to Alzheimer's disease.
    Orhan IE
    Curr Med Chem; 2012; 19(14):2252-61. PubMed ID: 22414107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
    Riaz S; Khan IU; Bajda M; Ashraf M; Qurat-Ul-Ain ; Shaukat A; Rehman TU; Mutahir S; Hussain S; Mustafa G; Yar M
    Bioorg Chem; 2015 Dec; 63():64-71. PubMed ID: 26451651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alkaloids as a source of potential anticholinesterase inhibitors for the treatment of Alzheimer's disease.
    Konrath EL; Passos Cdos S; Klein LC; Henriques AT
    J Pharm Pharmacol; 2013 Dec; 65(12):1701-25. PubMed ID: 24236981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low Plasma Cholinesterase Activities are Associated with Deficits in Spatial Orientation, Reduced Ability to Perform Basic Activities of Daily Living, and Low Body Mass Index in Patients with Progressed Alzheimer's Disease.
    Dingova D; Fazekas T; Okuliarova P; Strbova J; Kucera M; Hrabovska A
    J Alzheimers Dis; 2016; 51(3):801-13. PubMed ID: 26890780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit.
    Giacobini E; Spiegel R; Enz A; Veroff AE; Cutler NR
    J Neural Transm (Vienna); 2002 Jul; 109(7-8):1053-65. PubMed ID: 12111443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential laminar distribution of acetylcholinesterase and butyrylcholinesterase containing tangles in the cerebral cortex of Alzheimer's disease.
    Coleman AE; Geula C; Price BH; Mesulam MM
    Brain Res; 1992 Nov; 596(1-2):340-4. PubMed ID: 1467998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 6-Hydroxy- and 6-methoxy-beta-carbolines as acetyl- and butyrylcholinesterase inhibitors.
    Schott Y; Decker M; Rommelspacher H; Lehmann J
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5840-3. PubMed ID: 16945529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural products and their derivatives as cholinesterase inhibitors in the treatment of neurodegenerative disorders: an update.
    Loizzo MR; Tundis R; Menichini F; Menichini F
    Curr Med Chem; 2008; 15(12):1209-28. PubMed ID: 18473814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.